BRIDGEWATER, N.J., June 16, 2021 /PRNewswire/ — Messer, the world’s largest privately held industrial gas business, today announces plans to build a large-scale air separation unit (ASU) to manufacture liquid atmospheric products in Central Texas. The new air separation plant will produce medical and industrial gases which are essential to hospitals, food processors, metals manufacturing, oil and gas producers, aerospace industries, electronics fabricators and independent welding and gases distributors.
“Messer will extend our strong southwestern merchant gases supply network to meet growing customer demand in the region,” said Jens Luehring, President and CEO of Messer Americas. “Our expansion in this market has been on an upward trajectory for several years and we have been supplying customers from our plants in LaPorte and Terrell, Texas, as well as Lewisville, Arkansas.
Not only will the new plant expand our service capabilities to support the medium- and long-term growth of key accounts and industries around Central Texas, but it further supports our mission to become the premier supplier of choice for industrial, medical and specialty products in the Americas,” Luehring said.
About Messer Americas
Messer is the largest privately held industrial gas business in the world, and a leading industrial and medical gas company in North and South America. Messer offers over 120 years of expertise in industrial, medical, specialty, and electronic gases and safely delivers quality gases, related services and technology via an extensive production and distribution network. Messer Americas is part of Messer Group, representing a USD ~3.8 billion enterprise with presence in the Americas, Europe and Asia. For more information, visit: www.messeramericas.com.
SOURCE Messer Americas
GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…
Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…
Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at…
LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…
Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…